SCHEMBL2965582

SCHEMBL2965582

Cc1ccccc1-c1c(C)cc(Br)c2c1CC=C2

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
KCNA3 P22001 1/20 0.32
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
HEXA P06865 1/20 0.31
HEXB P07686 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2974774 0.89 ALDH1A1 (0.34) ALDH1A1KCNA3MAOAMAOBHEXA
SCHEMBL2974768 0.88 NUDT1 (0.32)
SCHEMBL2959810 0.85 DHFR (0.36) ALDH1A1MAOAMAOB
SCHEMBL2972633 0.83 MEN1 (0.32) ALDH1A1
SCHEMBL2967504 0.81 MAOA (0.32) MAOA
SCHEMBL2968175 0.79 NUDT1 (0.32)
SCHEMBL2961882 0.78
SCHEMBL2965580 0.77 MEN1 (0.36) ALDH1A1
SCHEMBL2972849 0.77 NUDT1 (0.32) MAOA
SCHEMBL2975183 0.76 DHFR (0.36) ALDH1A1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 ALDH1A1 4332/4885KCNA3 565/4885MAOA 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.